Enter your terms above and click the 'Search' button.

Showing articles 0 to 7 of 7 Filter Applied: multiple sclerosis,secondary progressive (Click to remove) Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis JAMA 32:175-187, Brown, J.W.L.,et al, 2019 Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review JNNP 84:420-426, La Mantia, L.,et al, 2013 How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS? Neurol 69:1498-1507, Brown,M.G.,et al, 2007 Mitoxantrone for Multiple Sclerosis in Clinical Practice Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004 The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis Neurol 61:1332-1338, Goodin,D.S.,et al, 2003 Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001 Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999 Showing articles 0 to 7 of 7